Biohaven Ltd. SEC filings BHVN

Biohaven Ltd. has 282 filings in SEC EDGAR's recent list, going back to Jul 1, 2022. Its latest annual report, Form 10-K, was filed on Mar 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.

Biohaven Ltd. SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Oct 29, 2026 Oct 29, 2026
10-Q Quarterly report Oct 29, 2026 Sep 30, 2026
8-K Current report
Regulation FD disclosure
Oct 22, 2026 Oct 22, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Oct 15, 2026 Oct 8, 2026
4 Insider transaction Sep 17, 2026 Sep 15, 2026
8-K Current report
Other events
Sep 10, 2026 Sep 4, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Aug 26, 2026 Aug 26, 2026
3 Initial insider ownership Aug 14, 2026 Aug 6, 2026
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2026 —
8-K Current report
Results of operations
Aug 10, 2026 Aug 10, 2026
10-Q Quarterly report Aug 10, 2026 Jun 30, 2026
8-K Current report
Officer or director change
Aug 7, 2026 Aug 3, 2026
3 Initial insider ownership Jul 17, 2026 Jul 9, 2026
8-K Current report
Officer or director change
Jul 9, 2026 Jul 9, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 8, 2026 —
8-K Current report
Regulation FD disclosure
May 27, 2026 May 26, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
8-K Current report
Other events
May 5, 2026 May 4, 2026
424B5 Prospectus supplement May 4, 2026 —
S-3ASR Automatic shelf registration May 4, 2026 —
10-Q Quarterly report May 4, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 4, 2026 May 4, 2026
8-K Current report
Shareholder vote results
May 4, 2026 Apr 28, 2026
4 Insider transaction Apr 30, 2026 Apr 28, 2026
4 Insider transaction Apr 30, 2026 Apr 28, 2026
4 Insider transaction Apr 30, 2026 Apr 28, 2026
4 Insider transaction Apr 30, 2026 Apr 28, 2026
4 Insider transaction Apr 30, 2026 Apr 28, 2026
4 Insider transaction Apr 30, 2026 Apr 28, 2026
4 Insider transaction Apr 30, 2026 Apr 28, 2026
4 Insider transaction Mar 19, 2026 Mar 17, 2026
DEFA14A Additional proxy material Mar 13, 2026 —
DEF 14A Proxy statement Mar 13, 2026 Apr 28, 2026
4/A Form 4/a Mar 9, 2026 Mar 4, 2025
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
8-K Current report
Results of operations
Mar 2, 2026 Mar 2, 2026
S-8 Employee stock plan registration Mar 2, 2026 —
10-K Annual report Mar 2, 2026 Dec 31, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 6, 2026 —
8-K Current report
Regulation FD disclosure
Jan 12, 2026 Jan 12, 2026
4 Insider transaction Jan 7, 2026 Jan 5, 2026
4 Insider transaction Jan 7, 2026 Jan 5, 2026
4 Insider transaction Jan 7, 2026 Jan 5, 2026
4 Insider transaction Jan 7, 2026 Jan 5, 2026
4 Insider transaction Jan 7, 2026 Jan 5, 2026
8-K Current report
Other events
Jan 7, 2026 Jan 6, 2026
4 Insider transaction Nov 18, 2025 Nov 17, 2025
4 Insider transaction Nov 17, 2025 Nov 13, 2025
4 Insider transaction Nov 17, 2025 Nov 13, 2025
4 Insider transaction Nov 17, 2025 Nov 13, 2025
SCHEDULE 13G Ownership over 5% (passive) Nov 14, 2025 —
8-K Current report
Other events
Nov 13, 2025 Nov 13, 2025
424B5 Prospectus supplement Nov 13, 2025 —
424B5 Prospectus supplement Nov 12, 2025 —
10-Q Quarterly report Nov 10, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 10, 2025 Nov 10, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 30, 2025 —
8-K Current report
Regulation FD disclosure
Aug 22, 2025 Aug 21, 2025
8-K Current report
Other events
Aug 15, 2025 Aug 15, 2025
424B7 Filing Aug 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
10-Q Quarterly report Aug 11, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 11, 2025 Aug 11, 2025
8-K Current report
Regulation FD disclosure
Jun 4, 2025 Jun 4, 2025
8-K Current report
Regulation FD disclosure
May 15, 2025 May 14, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2025 —
10-Q Quarterly report May 12, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 12, 2025 May 12, 2025
8-K Current report
Shareholder vote results
May 7, 2025 May 5, 2025
4 Insider transaction May 7, 2025 May 5, 2025
4 Insider transaction May 7, 2025 May 5, 2025
4 Insider transaction May 7, 2025 May 5, 2025
4 Insider transaction May 7, 2025 May 5, 2025
4 Insider transaction May 7, 2025 May 5, 2025
4 Insider transaction May 7, 2025 May 5, 2025
4 Insider transaction May 7, 2025 May 5, 2025
8-K Current report
Material agreement, New debt, Regulation FD disclosure
Apr 28, 2025 Apr 28, 2025
DEFA14A Additional proxy material Mar 18, 2025 —
DEF 14A Proxy statement Mar 18, 2025 May 5, 2025
4 Insider transaction Mar 5, 2025 Mar 4, 2025
4/A Form 4/a Mar 5, 2025 Apr 22, 2024
8-K Current report
Results of operations
Mar 3, 2025 Mar 3, 2025
10-K Annual report Mar 3, 2025 Dec 31, 2024
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
8-K Current report
Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
4 Insider transaction Jan 7, 2025 Jan 5, 2025
4 Insider transaction Jan 7, 2025 Jan 5, 2025
4 Insider transaction Jan 7, 2025 Jan 5, 2025
4 Insider transaction Jan 7, 2025 Jan 5, 2025
4 Insider transaction Jan 7, 2025 Jan 5, 2025
4 Insider transaction Dec 31, 2024 Dec 30, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 4, 2024 —
CT ORDER Filing Oct 22, 2024 —
4 Insider transaction Oct 3, 2024 Oct 2, 2024
4 Insider transaction Oct 3, 2024 Oct 2, 2024
8-K Current report
Other events
Oct 2, 2024 Oct 2, 2024
424B5 Prospectus supplement Oct 1, 2024 —
424B5 Prospectus supplement Sep 30, 2024 —
4 Insider transaction Sep 25, 2024 Sep 24, 2024
8-K Current report
Regulation FD disclosure, Other events
Sep 23, 2024 Sep 23, 2024
8-K Current report
Other events
Aug 16, 2024 Aug 16, 2024
424B7 Filing Aug 16, 2024 —
8-K Current report
Other events
Aug 16, 2024 Aug 16, 2024
424B5 Prospectus supplement Aug 16, 2024 —
10-Q Quarterly report Aug 9, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
4 Insider transaction Jul 19, 2024 Jul 18, 2024
4 Insider transaction Jun 20, 2024 Jun 17, 2024
4 Insider transaction May 31, 2024 May 30, 2024
8-K Current report
Other events
May 17, 2024 May 17, 2024
424B7 Filing May 17, 2024 —
4 Insider transaction May 15, 2024 May 13, 2024
4 Insider transaction May 14, 2024 May 13, 2024
S-8 Employee stock plan registration May 9, 2024 —
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
4 Insider transaction May 2, 2024 Apr 30, 2024
4 Insider transaction May 2, 2024 Apr 30, 2024
4 Insider transaction May 2, 2024 Apr 30, 2024
4 Insider transaction May 2, 2024 Apr 30, 2024
4 Insider transaction May 2, 2024 Apr 30, 2024
4 Insider transaction May 2, 2024 Apr 30, 2024
4 Insider transaction May 2, 2024 Apr 30, 2024
8-K Current report
Shareholder vote results
May 1, 2024 Apr 30, 2024
4 Insider transaction Apr 25, 2024 Apr 24, 2024
4 Insider transaction Apr 23, 2024 Apr 22, 2024
4 Insider transaction Apr 23, 2024 Apr 22, 2024
4 Insider transaction Apr 23, 2024 Apr 22, 2024
8-K Current report
Other events
Apr 22, 2024 Apr 22, 2024
424B5 Prospectus supplement Apr 19, 2024 —
424B5 Prospectus supplement Apr 17, 2024 —
8-K Current report
Regulation FD disclosure
Apr 15, 2024 Apr 15, 2024
4 Insider transaction Apr 5, 2024 Apr 5, 2024
4 Insider transaction Apr 5, 2024 Apr 5, 2024
DEFA14A Additional proxy material Mar 18, 2024 —
DEF 14A Proxy statement Mar 18, 2024 Apr 30, 2024
8-K Current report
Other events
Mar 12, 2024 Mar 12, 2024
424B7 Filing Mar 12, 2024 —
4 Insider transaction Mar 8, 2024 Mar 8, 2024
4 Insider transaction Mar 8, 2024 Mar 8, 2024
8-K Current report
Results of operations
Feb 29, 2024 Feb 29, 2024
10-K Annual report Feb 29, 2024 Dec 31, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G Ownership over 5% (passive) Feb 6, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 23, 2024 —
4 Insider transaction Jan 10, 2024 Jan 8, 2024
4 Insider transaction Jan 10, 2024 Jan 8, 2024
8-K Current report
Regulation FD disclosure
Jan 8, 2024 Jan 8, 2024
4 Insider transaction Jan 4, 2024 Jan 2, 2024
4 Insider transaction Jan 4, 2024 Jan 2, 2024
4 Insider transaction Jan 4, 2024 Jan 2, 2024
4 Insider transaction Jan 4, 2024 Jan 2, 2024
4 Insider transaction Jan 4, 2024 Jan 2, 2024
4 Insider transaction Dec 29, 2023 Dec 29, 2023
144 Notice of proposed sale Dec 29, 2023 —
8-K Current report
Results of operations
Nov 14, 2023 Nov 14, 2023
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
4 Insider transaction Nov 6, 2023 Nov 2, 2023
4 Insider transaction Nov 6, 2023 Nov 2, 2023
4 Insider transaction Nov 6, 2023 Nov 2, 2023
4 Insider transaction Nov 6, 2023 Nov 2, 2023
4 Insider transaction Nov 6, 2023 Nov 2, 2023
SC 13G Ownership over 5% (passive) Oct 18, 2023 —
4 Insider transaction Oct 10, 2023 Oct 5, 2023
4 Insider transaction Oct 10, 2023 Oct 5, 2023
4 Insider transaction Oct 6, 2023 Oct 5, 2023
4 Insider transaction Oct 6, 2023 Oct 4, 2023
8-K Current report
Other events
Oct 5, 2023 Oct 5, 2023
424B5 Prospectus supplement Oct 4, 2023 —
8-K Current report
Other events
Oct 3, 2023 Oct 2, 2023
424B5 Prospectus supplement Oct 2, 2023 —
424B5 Prospectus supplement Oct 2, 2023 —
S-3ASR Automatic shelf registration Oct 2, 2023 —
8-K Current report
Regulation FD disclosure
Sep 27, 2023 Sep 27, 2023
4 Insider transaction Aug 31, 2023 Aug 30, 2023
4 Insider transaction Aug 7, 2023 Aug 4, 2023
10-Q Quarterly report Jul 31, 2023 Jun 30, 2023
8-K Current report
Results of operations
Jul 31, 2023 Jul 31, 2023
8-K Current report
Regulation FD disclosure
Jul 28, 2023 Jul 27, 2023
8-K Current report
Regulation FD disclosure
May 31, 2023 May 31, 2023
8-K Current report
Results of operations
May 12, 2023 May 12, 2023
S-8 Employee stock plan registration May 12, 2023 —
10-Q Quarterly report May 12, 2023 Mar 31, 2023
4 Insider transaction May 4, 2023 May 2, 2023
4 Insider transaction May 4, 2023 May 2, 2023
4 Insider transaction May 4, 2023 May 2, 2023
4 Insider transaction May 4, 2023 May 2, 2023
4 Insider transaction May 4, 2023 May 2, 2023
4 Insider transaction May 4, 2023 May 2, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
BHVN (NYSE)
Fiscal year ends
December 31
Incorporated in
Virgin Islands, British
Headquarters
New Haven, CT
SEC filer status
Large accelerated filer
SEC CIK
1935979
Former names
Biohaven Research Ltd. (until Sep 14, 2022)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.